Please select the option that best describes you:
Topics:
Internal Medicine • Rheumatology • Hematology • Pediatric Hematology • Infectious Disease • HLH • Allergy & Immunology • Pulmonology • Dermatology • Systemic autoimmune diseases • Primary Immunodeficiency • Pediatric Oncology
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
Answer from: at Academic Institution
At our institution, we have comprised a multidisciplinary team to help treat these patients. The team or "HLH task force" as we like to call ourselves is comprised of a clinical immunologist, rheumatologist, dermatologist, critical care physician, hepatologist, BMT attending/hematologist, infectious...
Sign in or Register to read more
Answer from: at Community Practice
Agree on a multi-specialty approach for early input regarding the assessment and management of sHLH/MAS. While the multi-system inflammatory phenotype of COVID-19 is unique, one outcome of the pandemic was accelerating this type of approach to patients admitted with multi-system organ dysfunction. E...